SDC1 and breast cancer: Interestingly, enhanced syndecan-1 shedding depends on the heparan sulfate degrading activity of heparanase,(29) consistent with our finding that heparanase enzymatic activity is required for the enhanced osteoclastogenic effect of the heparanase-high breast cancer cells.